A Malarstig

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. doi request reprint Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction
    Anders Malarstig
    Atherosclerosis Research Unit, Karolinska Institute, Stockholm, Sweden
    Arterioscler Thromb Vasc Biol 28:975-82. 2008
  2. pmc Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study
    Anders Malarstig
    Atherosclerosis Research Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
    Blood 114:1417-22. 2009
  3. doi request reprint Genetics of atherothrombosis and thrombophilia
    Anders Malarstig
    Atherosclerosis Research Unit, Department of Medicine, Solna, Sweden
    Curr Atheroscler Rep 12:159-66. 2010
  4. ncbi request reprint Plasma CD93 concentration is a potential novel biomarker for coronary artery disease
    A Malarstig
    Atherosclerosis Research Unit, Karolinska University Hospital, Stockholm, Sweden
    J Intern Med 270:229-36. 2011
  5. ncbi request reprint The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence
    S Meisgen
    Department of Medicine, Karolinska Institutet, Uppsala University, Uppsala, Sweden
    J Intern Med 275:640-51. 2014

Collaborators

Detail Information

Publications5

  1. doi request reprint Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction
    Anders Malarstig
    Atherosclerosis Research Unit, Karolinska Institute, Stockholm, Sweden
    Arterioscler Thromb Vasc Biol 28:975-82. 2008
    ..INF regulatory factor 5 (IRF5) is one of the mediators of downstream effects of TLRs. Several single nucleotide polymorphisms (SNPs) in the IRF5 gene have been found to be associated with systemic lupus erythematosus...
  2. pmc Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study
    Anders Malarstig
    Atherosclerosis Research Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
    Blood 114:1417-22. 2009
    ..Our findings implicate novel pathways in homocysteine metabolism, and highlight the need for investigation of the associated genes in the etiology of vascular diseases...
  3. doi request reprint Genetics of atherothrombosis and thrombophilia
    Anders Malarstig
    Atherosclerosis Research Unit, Department of Medicine, Solna, Sweden
    Curr Atheroscler Rep 12:159-66. 2010
    ....
  4. ncbi request reprint Plasma CD93 concentration is a potential novel biomarker for coronary artery disease
    A Malarstig
    Atherosclerosis Research Unit, Karolinska University Hospital, Stockholm, Sweden
    J Intern Med 270:229-36. 2011
    ..In addition, SNPs in the CD93 gene were studied in relation to plasma CD93 concentration and CD93 mRNA expression...
  5. ncbi request reprint The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence
    S Meisgen
    Department of Medicine, Karolinska Institutet, Uppsala University, Uppsala, Sweden
    J Intern Med 275:640-51. 2014
    ..The main aim of this study was to identify foetal susceptibility genes on chromosome six for Ro/SSA autoantibody-mediated congenital heart block...